Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation

Bibliographic Details
Main Authors:	Davison, G, Novitzky, N, Kline, A, Thomas, V, Abrahams, L, Hale, G, Waldmann, H
Format:	Journal article
Published:	1998

Similar Items

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
by: Davison, G, et al.
Published: (1998)

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
by: Davison, G, et al.
Published: (2000)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
by: Novitzky, N, et al.
Published: (2002)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
by: Novitzky, N, et al.
Published: (1997)

Immune reconstitution following haematopoietic stem cell transplantation.
by: Davison, G, et al.
Published: (2000)

T-cell depletion of peripheral blood progenitor cell grafts is associated with effective protection from GVHD and rapid haematopoietic reconstitution.
by: Novitzky, N, et al.
Published: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
by: Novitzky, N, et al.
Published: (1997)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
by: Slavin, S, et al.
Published: (1985)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
by: Hale, G, et al.
Published: (1997)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
by: Novitzky, N, et al.
Published: (1999)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
by: Fibbe, W, et al.
Published: (1993)

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
by: Ferrara James L.M.
Published: (2002-01-01)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
by: Mackinnon, S, et al.
Published: (1988)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
by: Chakrabarti, S, et al.
Published: (2003)

Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
by: Barge, R, et al.
Published: (2001)

Addition of cyclosporin post transplantation decreases GvHD without enhancing the adverse effect of T-cell depletion with CAMPATH-1H "in the bag": The cape town experience
by: Novitzky, N, et al.
Published: (2003)

In marrow aplasia reduced-intensity conditioning and T-cell depletion of cytokine mobilised stem cells provides good engraftment without GvHD
by: Novitzky, N, et al.
Published: (2006)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
by: Apperley, J, et al.
Published: (1985)

Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion.
by: Cornish, J, et al.
Published: (1996)

Reconstituição imunológica após o transplante de medula óssea alogênico Immunology reconstitution after allogeneic bone marrow transplantation
by: Maria A. L. Reis, et al.
Published: (2004-01-01)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
by: Hale, G, et al.
Published: (1998)

RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN
by: A. khodabeh., et al.
Published: (1998-06-01)

RESULTS OF ALLOGENIC BONE MARROW TRANSPLANTATION IN CML IN IRAN
by: A. khodabeh., et al.
Published: (1998-07-01)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
by: Novitzky, N, et al.
Published: (2004)

Transplantation of allogenic bone marrow in chronic myeloid leukemias
by: L S Lyubimova, et al.
Published: (2004-07-01)

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
by: Naparstek, E, et al.
Published: (1995)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
by: Novitzky, N, et al.
Published: (2004)

Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia.
by: Novitzky, N, et al.
Published: (2004)

Excessive T-cell depletion adversely affects transplant-related mortality following allogeneic stem cell transplantation.
by: Chakraverty, R, et al.
Published: (2000)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
by: Chenchen Zhao, et al.
Published: (2022-05-01)

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions.
by: D'Sa, S, et al.
Published: (2003)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
by: Waldmann, H, et al.
Published: (1987)

BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS FOR CML IN CHRONIC PHASE
by: Cullis, J, et al.
Published: (1991)

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
by: Novitzky, N, et al.
Published: (2005)